{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T04:18:26Z","timestamp":1744949906070,"version":"3.40.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012401","name":"Beijing Science and Technology Planning Project","doi-asserted-by":"publisher","award":["Z231100004823003"],"award-info":[{"award-number":["Z231100004823003"]}],"id":[{"id":"10.13039\/501100012401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2307801","2022YFC0870600"],"award-info":[{"award-number":["2023YFC2307801","2022YFC0870600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.reprotox.2025.108878","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T16:20:16Z","timestamp":1741105216000},"page":"108878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Developmental and reproductive toxicity (DART) study of a novel SARS-CoV-2 tetravalent recombinant protein vaccine (SCTV01E) in rats"],"prefix":"10.1016","volume":"134","author":[{"given":"Xiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jilei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaojian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaozheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangzhi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reprotox.2025.108878_bib1","unstructured":"World Health Organization, Number of COVID-19 cases reported to WHO (cumulative total), 2024. \u3008https:\/\/data.who.int\/dashboards\/covid19\/cases?n=c\u3009, (Accessed 18 August 2024)."},{"key":"10.1016\/j.reprotox.2025.108878_bib2","unstructured":"World Health Organization, Number of COVID-19 deaths reported to WHO (cumulative total), 2024. \u3008https:\/\/data.who.int\/dashboards\/covid19\/deaths?n=c\u3009, (Accessed 18 August 2024)."},{"issue":"4","key":"10.1016\/j.reprotox.2025.108878_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110729","article-title":"Structural and functional impact by SARS-CoV-2 omicron spike mutations","volume":"39","author":"Zhang","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.reprotox.2025.108878_bib4","unstructured":"World Health Organization, Coronavirus disease (COVID-19), 2024. \u3008https:\/\/www.who.int\/health-topics\/coronavirus#tab=tab_1\u3009, (Accessed 18 August 2024)."},{"issue":"3","key":"10.1016\/j.reprotox.2025.108878_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.reprotox.2025.108878_bib6","unstructured":"Acro biosystems, An Overview of Different COVID-19 Vaccines, 2021. \u3008https:\/\/www.acrobiosystems.com\/A1374-An-Overview-of-Different-COVID-19-Vaccines.html?gad_source=1&gclid=EAIaIQobChMIofPTuJ7ghwMVkhuDAx0UaQcsEAAYASAAEgKbF_D_BwE\u3009, (Accessed 18 August 2024)."},{"issue":"9","key":"10.1016\/j.reprotox.2025.108878_bib7","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.cell.2021.03.013","article-title":"Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity","volume":"184","author":"Garcia-Beltran","year":"2021","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.reprotox.2025.108878_bib8","first-page":"328","article-title":"A comparative overview of SARS-CoV-2 and its variants of concern","volume":"30","author":"Ahmad","year":"2022","journal-title":"Le. Infez. Med."},{"key":"10.1016\/j.reprotox.2025.108878_bib9","unstructured":"A. Aleem, A.B. Akbar Samad, S. Vaqar, Emerging variants of SARS-CoV-2 and novel therapeutics against coronavirus (COVID-19) [Updated 2023 May 8], in: StatPearls [Internet], StatPearls Publishing, Treasure Island (FL), 2024. Available from: \u3008https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK570580\/\u3009."},{"key":"10.1016\/j.reprotox.2025.108878_bib10","article-title":"Safety and immunogenicity of an inactivated COVID-19 vaccine, WIBP-CorV, in healthy children: interim analysis of a randomized, double-blind, controlled, phase 1\/2 trial","volume":"13","author":"Xia","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.reprotox.2025.108878_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2381","article-title":"Evolution of the SARS-CoV-2 omicron variants BA.1\u2013BA.5: implications for immune escape and transmission","volume":"32","author":"Shrestha","year":"2022","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.reprotox.2025.108878_bib12","unstructured":"Pfizer, Pfizer and BioNTech Report New Data on Omicron BA.4\/BA.5-Adapted Bivalent Booster Demonstrating Improved Immune Response Against Emerging Omicron Sublineages, 2022. \u3008https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-and-biontech-report-new-data-omicron-ba4ba5-adapted\u3009, (Accessed 18 August 2024)."},{"key":"10.1016\/j.reprotox.2025.108878_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102195","article-title":"Safety and immunogenicity of multivalent SARS-CoV-2 protein vaccines: a randomized phase 3 trial","volume":"64","author":"Hannawi","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"8","key":"10.1016\/j.reprotox.2025.108878_bib14","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1007\/s11427-022-2207-7","article-title":"A spike-trimer protein-based tetravalent COVID-19 vaccine elicits enhanced breadth of neutralization against SARS-CoV-2 omicron subvariants and other variants","volume":"66","author":"Wang","year":"2023","journal-title":"Sci. China Life Sci."},{"issue":"1","key":"10.1016\/j.reprotox.2025.108878_bib15","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1038\/s41467-023-39766-x","article-title":"Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men","volume":"14","author":"Hannawi","year":"2023","journal-title":"Nat. Commun."},{"issue":"15","key":"10.1016\/j.reprotox.2025.108878_bib16","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1042\/CS20210284","article-title":"Role of ACE2 in pregnancy and potential implications for COVID-19 susceptibility","volume":"135","author":"Azinheira Nobrega Cruz","year":"2021","journal-title":"Clin. Sci. (Lond. Engl.: 1979)"},{"key":"10.1016\/j.reprotox.2025.108878_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104386","article-title":"Safety and immunogenicity of a bivalent SARS-CoV-2 protein booster vaccine, SCTV01C, in adults previously vaccinated with mRNA vaccine: a randomized, double-blind, placebo-controlled phase 1\/2 clinical trial","volume":"87","author":"Hannawi","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.reprotox.2025.108878_bib18","unstructured":"Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals, ICH\/M3 (R2), 2009."},{"key":"10.1016\/j.reprotox.2025.108878_bib19","unstructured":"Detection of Reproductive and Developmental Toxicity for human Pharmaceuticals, ICH S5 (R3), 2020."},{"key":"10.1016\/j.reprotox.2025.108878_bib20","unstructured":"Guidelines on the non-clinical evaluation of vaccine adjuvants and adjuvanted vaccines, Annex 2, WHO, TRS No 987, 2014."},{"key":"10.1016\/j.reprotox.2025.108878_bib21","unstructured":"Considerations for Developmental Toxicity Studies for Preventive and Therapeutic Vaccines for Infectious Disease Indications, U.S. FDA, 2006."},{"key":"10.1016\/j.reprotox.2025.108878_bib22","unstructured":"General Considerations for Preclinical Toxicity Studies for Preventive Vaccines, CFDA, 2005."},{"key":"10.1016\/j.reprotox.2025.108878_bib23","unstructured":"Reproduction\/Developmental Toxicity Screening Test, OECD 421, 2016."},{"issue":"12","key":"10.1016\/j.reprotox.2025.108878_bib24","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1080\/21645515.2018.1495301","article-title":"Immunology and efficacy of MF59-adjuvanted vaccines","volume":"14","author":"Ko","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.reprotox.2025.108878_bib26","unstructured":"OECD Principles of Good Laboratory Practice (revised in 1997)."},{"key":"10.1016\/j.reprotox.2025.108878_bib27","unstructured":"China Food and Drug Administration (CFDA), Good Laboratory Practice, Decree No. 34, 2017."},{"issue":"117","key":"10.1016\/j.reprotox.2025.108878_bib28","first-page":"53569","article-title":"A battery of motor tests in a neonatal mouse model of cerebral palsy","author":"Feather-Schussler","year":"2016","journal-title":"J. Vis. Exp.: JoVE"},{"issue":"1","key":"10.1016\/j.reprotox.2025.108878_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5214\/ans.0972.7531.260106","article-title":"Negative geotaxis: an early age behavioral hallmark to VPA rat model of autism","volume":"26","author":"Ruhela","year":"2019","journal-title":"Ann. Neurosci."},{"key":"10.1016\/j.reprotox.2025.108878_bib30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.reprotox.2021.05.007","article-title":"Lack of effects on female fertility and prenatal and postnatal offspring development in rats with BNT162b2, a mRNA-based COVID-19 vaccine","volume":"103","author":"Bowman","year":"2021","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2025.108878_bib31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.reprotox.2021.07.010","article-title":"Developmental and reproductive safety of AZD1222 (ChAdOx1 nCoV-19) in mice","volume":"104","author":"Stebbings","year":"2021","journal-title":"Reprod. Toxicol."},{"issue":"32","key":"10.1016\/j.reprotox.2025.108878_bib32","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1016\/j.vaccine.2022.06.020","article-title":"Safety and protective capability of an inactivated SARS-CoV-2 vaccine on pregnancy, lactation and the growth of offspring in hACE2 mice","volume":"40","author":"Lin","year":"2022","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.reprotox.2025.108878_bib33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41541-023-00673-3","article-title":"Developmental and reproductive toxicity of a recombinant protein subunit COVID-19 vaccine (ZF2001) in rats","volume":"8","author":"Song","year":"2023","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.reprotox.2025.108878_bib34","unstructured":"FCC H1N1sw Vaccine, Novartis Vaccines and Diagnostics 2.6.1 Introduction, 2009."},{"issue":"7","key":"10.1016\/j.reprotox.2025.108878_bib35","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.vaccine.2009.11.077","article-title":"Exposure to MF59-adjuvanted influenza vaccines during pregnancy\u2013a retrospective analysis","volume":"28","author":"Tsai","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.reprotox.2025.108878_bib36","unstructured":"Reproductive and Developmental Toxicities \u2013 Integrating Study Results to Assess Concerns, FDA, 2011."},{"issue":"1","key":"10.1016\/j.reprotox.2025.108878_bib37","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1152\/physrev.1972.52.1.198","article-title":"Kinetics of spermatogenesis in mammals: seminiferous epithelium cycle and spermatogonial renewal","volume":"52","author":"Clermont","year":"1972","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.reprotox.2025.108878_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-39304-1","article-title":"Generation of rat offspring using spermatids produced through in vitro spermatogenesis","volume":"13","author":"Matsumura","year":"2023","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/j.reprotox.2025.108878_bib39","first-page":"2195","article-title":"How to successfully carry out nonclinical reproductive toxicity study on new drugs (in Chinese)","volume":"20","author":"Sun","year":"2011","journal-title":"Chin. J. New Drugs"},{"issue":"4","key":"10.1016\/j.reprotox.2025.108878_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2022.115807","article-title":"Reliable estimation of SARS-CoV-2 anti-spike protein IgG titers from single dilution optical density values in serologic surveys","volume":"104","author":"Andrade Belitardo","year":"2022","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"12","key":"10.1016\/j.reprotox.2025.108878_bib41","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01926-19","article-title":"Diagnostic approach for arboviral infections in the United States","volume":"58","author":"Piantadosi","year":"2020","journal-title":"J. Clin. Microbiol."}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623825000498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623825000498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T19:16:27Z","timestamp":1744917387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623825000498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":40,"alternative-id":["S0890623825000498"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2025.108878","relation":{},"ISSN":["0890-6238"],"issn-type":[{"type":"print","value":"0890-6238"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developmental and reproductive toxicity (DART) study of a novel SARS-CoV-2 tetravalent recombinant protein vaccine (SCTV01E) in rats","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2025.108878","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108878"}}